Filter News
Area of Research
- (-) Neutron Science (14)
- Advanced Manufacturing (3)
- Biology and Environment (11)
- Clean Energy (27)
- Computational Engineering (1)
- Computer Science (2)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (11)
- Fusion Energy (1)
- Isotope Development and Production (1)
- Isotopes (3)
- Materials (30)
- Materials for Computing (3)
- National Security (13)
- Nuclear Science and Technology (8)
- Quantum information Science (1)
- Supercomputing (49)
News Topics
- (-) Biomedical (4)
- (-) Computer Science (6)
- (-) Frontier (1)
- (-) Microscopy (1)
- (-) Nuclear Energy (1)
- (-) Quantum Science (4)
- (-) Space Exploration (1)
- 3-D Printing/Advanced Manufacturing (3)
- Artificial Intelligence (1)
- Big Data (1)
- Bioenergy (3)
- Biology (4)
- Biotechnology (1)
- Climate Change (1)
- Composites (1)
- Coronavirus (5)
- Cybersecurity (1)
- Decarbonization (1)
- Energy Storage (2)
- Environment (3)
- Fusion (1)
- High-Performance Computing (1)
- Materials (6)
- Materials Science (13)
- Nanotechnology (6)
- National Security (1)
- Neutron Science (40)
- Physics (7)
- Security (1)
- Summit (4)
- Sustainable Energy (2)
- Transportation (2)
Media Contacts
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
A team led by the Department of Energy’s Oak Ridge National Laboratory synthesized a tiny structure with high surface area and discovered how its unique architecture drives ions across interfaces to transport energy or information.
An international team of researchers has discovered the hydrogen atoms in a metal hydride material are much more tightly spaced than had been predicted for decades — a feature that could possibly facilitate superconductivity at or near room temperature and pressure.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.